Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brexit Reflections For UK IVDs: Harmonized Regulation, Staff Issues Key

Executive Summary

The UK in vitro diagnostics industry has been working on two initiatives that set out its views on how to secure a stable and competitive future for the national industry in the months following the country's vote to leave the EU.

You may also be interested in...

UK Outlook 2018: Companies Need To Quantify Brexit Risk And Find A New Place In The World

With the clock running down on Brexit, bemused UK medtechs are ready to seize any information that helps them chart a way forward on trading with the EU in the absence of solid directions from the government. Frustrated by the Brexit vacuum, local manufacturers are actively looking to build businesses beyond the EU and focusing on innovation adoption at home, as ABHI policy director Richard Phillips explains.

Amid Reforms, Brexit, UK IVD Firms Battle Funding And Adoption Issues

The EU In Vitro Diagnostics Regulation and Brexit loom large for UK IVD companies, but manufacturers serving the $1.6bn UK IVD market have many other competing concerns. It’s the most challenging period in more than 15 years, according to the British In Vitro Diagnostics Association Chief Executive Doris-Ann Williams.

UK Medtech Presses For Federation Structure In Post-Brexit Environment

A national federation of medtech associations is being proposed by parts of the UK industry, which often feels muscled out of the debate by pharma for big issues like handling the country's exit from the EU. The argument is that a less fragmented sector voice would have more influence on government decisions.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts